Provincial Respiratory Surveillance Report

COVID-19 and Seasonal Influenza

2022-2023


This weekly report provides a current epidemiological update on the intensity and severity of respiratory activity in Manitoba including laboratory confirmed activity of both COVID-19 and seasonal influenza. Surveillance data include syndromic indicators, laboratory testing, associated hospitalization and mortality, and outbreaks. Updates around immunization coverage in COVID-19 and seasonal influenza are also included.

Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 10:00am every Friday.

Week 48 (November 27 – December 3)

About epidemiological week

Due to an influx of influenza laboratory reports this respiratory season, Manitoba Health is experiencing delays in the documentation of laboratory results within the provincial Public Health Information Management System (PHIMS). As s result, the influenza case counts for week 48 are lower than expected. We anticipate an update to these data in next week's report.

Data extracted up to 1:00 am on December 8, 2022
Next reporting date: December 16, 2022

COVID-19 vaccination / Seasonal Influenza vaccination

COVID-19: Decreased Activity

COVID-19 activity in Week 48 decreased from the previous week. COVID-19 associated hospital admissions continued to decrease in Week 48. Laboratory detection is substantively lower compared to the same time period in the previous two years. Older adults continue to be at higher risk for COVID-19 infections and associated hospital admissions and fatalities.

As of December 3, in all Manitoba residents, 78.0% have received at least two doses of COVID-19 vaccines. Additionally, 20.3% have received at least one dose within the last six months.

Wastewater surveillance data by December 1 indicated sustained activity of COVID-19 in Winnipeg and Brandon.

Cases

About cases

  • Cases this week: 251
  • Total cases: 6480
More Analyses

Testing

About testing

This week

  • Average daily specimens: 388
  • Weekly positivity rate: 14.5%

Total

  • Tested people: 32,118
  • Population tested: 2.3%
  • Specimens tested: 49,278
  • Positivity rate: 21.2%
More Analyses

Severity

About associated severity

Severe outcomes this week

  • Hospital admissions: 76
    • ICU admissions3: 7
  • Deaths: <5

Total severe outcomes

  • Hospital admissions: 2,045
    • ICU admissions: 230
  • Deaths: 199
More Analyses

Outbreaks

About outbreaks

COVID-19 outbreaks this week

  • In long-term care facilities: 14
  • In hospitals: 1
  • In other settings: 0

Total COVID-19 outbreaks

  • In long-term care facilities: 168
  • In hospitals: 74
  • In other settings: 1
More Analyses

Seasonal Influenza: Similar Activity

Influenza activity in Week 48 was similar to the previous week. The case counts in Week 48 were lower than expected as a result of delays in the documentation of laboratory results within PHIMS. This week, influenza A test positivity slightly decreased to 19.5% and continued to be lower than that was observed nationally. Overall, the start of increase in activity this season is earlier than would be expected for this time of year. The predominant circulating strain is influenza A (H3N2). Up to Week 48 this season, children below the age of five years are at the highest risk for influenza infection. This age group accounted for 12% of all influenza cases and 20% of associated hospital admissions.

At the same time, other respiratory viruses continue to co-circulate. RSV test positivity increased to 4.0% in Week 48 from 2.2% in the previous week.

Cases

Cases this week

  • Influenza A: 120
  • Influenza B: 0

Total cases

  • Influenza A: 989
  • Influenza B: <5
More Analyses

Testing

Influenza testing this week

  • Average daily specimens: 289
  • Influenza A positivity rate: 19.5%
  • Influenza B positivity rate: 0

Other respiratory pathogens this week

  • RSV4 positivity rate: 4.0%
  • RSV detections: 80
More Analyses

Severity

Severe outcomes this week

  • Hospital admissions: <5
    • ICU admissions: <5
  • Deaths: <5

Total severe outcomes

  • Hospital admissions: 171
    • ICU admissions: 6
  • Deaths: 12
More Analyses

Outbreaks

Influenza outbreaks this week

  • Influenza A: 3
  • Influenza B: 0

Total influenza outbreaks

  • Influenza A: 20
  • Influenza B: 0
More Analyses

Syndromic Indicators: Similar Activity

The activity level in all syndromic indicators has increased in the last few weeks indicating an increase in respiratory activity in the community and in primary care. In Week 48, activity in two syndromic indicators continued to increase.

However, the daily respiratory related visits to emergency departments/urgent care decreased in week 48 from the previous week.

FluWatchers

About FluWatchers

Participants reporting this week: 602

Reporting fever and cough: 4.0%

More Analyses

Physician Visits

About sentinel physicians

Influenza Like Illness (ILI) Visits to sentinel physicians this week: 6.4%

More Analyses

Antiviral

About Antiviral

Units of antiviral dispensed from pharmacies this week: 29


Total influenza isolates resistant to antiviral this season in Canada

  • Oseltamivir: 0
  • Zanamivir: 0
More Analyses

ED Visits

About emergency room visits

Respiratory visits to emergency department (ED) this week: 2302

More Analyses

Important Notes

  1. Data about COVID-19 and influenza cases are extracted from PHIMS.
  2. Numbers are subject to change. Missed events in the current report due to reporting delays will be included in later reports when data become available. Cumulative totals include all events from start of the current season to end of the reporting week.
  3. ICU admissions were included in hospital admissions, and include adult and pediatric cases.
  4. RSV - Respiratory syncytial virus.

COVID-19

Cases

Figure 1. Weekly Cases of COVID-19 by Season, Manitoba, 2020 – 2022 (July through June)

Back


Figure 2. Sex and Age Distribution of COVID-19 Cases, Manitoba, July 3, 2022 – December 3, 2022

Back


Figure 3. Incidence Rate (/10,000 Population) of COVID-19 Cases by Age Group and Week of Public Health Report Date, Manitoba, July 3, 2022 – December 3, 2022

Back


Figure 4. Cases of COVID-19 by Health Region and Public Health Report Date, Manitoba, August 1, 2022 – December 3, 2022

Back


Table 1. Cases of COVID-19 and Incidence Rate (/10,000 population) by Health Region, Manitoba, July 3, 2022 – December 3, 2022

Helath region Total cases Cases this week Incidence rate this week Age-standardized incidence rate* this week
Winnipeg RHA 3845 135 1.7 1.7
Southern Health-Santé Sud 621 48 2.2 2.5
Interlake-Eastern RHA 694 22 1.6 1.5
Prairie Mountain Health 871 30 1.7 1.5
Northern Health Region 447 16 2.1 2.9

Note: * Age-standardized rates are used to account for differences in the age structure in health regions. The whole Manitoba population is used as the standard population.

Back


Testing

Figure 5. Average Daily Testing Volume and Positivity (%) for COVID-19 by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – December 3, 2022

Back


Severity

Figure 6. Severe Outcomes of COVID-19 by Week of Outcome Date, Manitoba, July 3, 2022 – December 3, 2022

Note. ICU admissions are not included in the hospital admissions.

Back


Figure 7. Age Distribution of Severe COVID-19 Cases This Week Compared to All Cases, Manitoba, July 3, 2022 – December 3, 2022

Back


Outbreaks

Figure 8. Weekly COVID-19 Outbreaks, Manitoba, 2020 – 2022

Note: All respiratory outbreaks include COVID-19 outbreaks, influenza outbreaks and the other respiratory outbreaks with known or unknown pathogens.

Back

Vaccination

Table 2. Coverage of COVID-19 Vaccinations, Manitoba, December 3, 2022

Age group (years) At least 1 dose At least 2 doses At least 1 dose within the last 6 months At least 1 dose of Bivalent
.5-04 9.0% 3.3% 8.9% 0.0%
05-11 55.9% 42.7% 9.1% 0.1%
12-17 82.8% 78.2% 8.9% 4.5%
18-29 88.5% 85.4% 7.0% 5.7%
30-39 84.5% 82.0% 11.5% 10.1%
40-49 87.8% 86.0% 15.6% 13.8%
50-59 87.1% 85.8% 23.6% 17.1%
60-69 94.7% 93.5% 40.8% 30.6%
70-79 >=95.0% >=95.0% 53.5% 42.1%
80+ >=95.0% >=95.0% 53.4% 44.0%
ALL 81.3% 78.0% 20.3% 14.9%

For more information, please visit COVID-19 vaccination coverage in Canada - Canada.ca

Back

Seasonal Influenza

Cases

Figure 9. Weekly Cases of Influenza by Season, Manitoba, 2019 – 2022 (July through June)

Back


Figure 10. Incidence Rate (/10,000 Population) of Influenza Cases by Age Group and Week of Public Health Report Date, 2018 – December 3, 2022

Back


Table 3. Cases of Influenza and Incidence Rate (/10,000 population) by Health Region, Manitoba, July 3, 2022 – December 3, 2022

Helath region Total cases Cases this week Incidence rate this week Age-standardized incidence rate* this week
Winnipeg RHA 511 58 0.7 0.7
Southern Health-Santé Sud 127 17 0.8 0.8
Interlake-Eastern RHA 153 25 1.8 2.1
Prairie Mountain Health 154 14 0.8 0.8
Northern Health Region 36 <5 0.5 0.6

Note: * Age-standardized rates are used to account for differences in the age structure in health regions. The whole Manitoba population is used as the standard population.

Back


Testing

Figure 11. Average Daily Testing Volume and Positivity (%) for Influenza by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – December 3, 2022

Back


Figure 12. Number of Positive Respiratory Virus Tests by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – December 3, 2022

Note. Other respiratory viruses include adenovirus, enterovirus/rhinovirus, human coronavirus (seasonal), human metapneumovirus and human parainfluenza virus.

Back


Severity

Figure 13. Severe Outcomes of Influenza by Week of Outcome Date, Manitoba, July 3, 2022 – December 3, 2022

Note. ICU admissions are not included in the hospital admissions.

Back


Figure 14. Age Distribution of Severe Influenza Cases in All Cases, Manitoba, July 3, 2022 – December 3, 2022

Back


Outbreaks

Figure 15. Weekly Respiratory and Influenza Outbreaks, Manitoba, 2019 – December 3, 2022

Note: All respiratory outbreaks include COVID-19 outbreaks, influenza outbreaks and the other respiratory outbreaks with known or unknown pathogens.

Back


Vaccinations

Table 5. Coverage of Influenza Vaccinations, Manitoba, September 1, 2022 – December 3, 2022

Age group Does Coverage percentage
0-4 10385 12.2%
5-17 26339 11.6%
18-49 73941 12.5%
50-64 68324 26.4%
65+ 129687 55.4%
All 310750 22.2%

Back


FluWatchers

Figure 16. Weekly FluWatchers Participants and Percentage Reporting Fever and Cough, Manitoba, 2019 – December 3, 2022

Back


Physician Visits

Figure 17. Weekly Percentage of ILI Related Visits to Sentinel Physicians, Manitoba, 2018 – December 3, 2022

Back


Antiviral

Figure 18. Weekly Units of Antiviral Dispensed from Pharmacies, Manitoba, 2018 – December 3, 2022

Back


ED Visits

Figure 19. Weekly Respiratory Visits to Emergency Department, Manitoba, 2017 – December 3, 2022

Back